She helped launch the ACA as a top Obama administration official.
Chiquita Brooks-LaSure is the leading candidate for the CMS administrator’s job in the Biden administration, Politico reported earlier today.
Brooks-LaSure has edged out North Carolina health secretary Mandy Cohen for the post, according to Politico.
Brooks-LaSure is now a managing director of Manatt Health, a consulting firm, but she has held several government positions. Her LinkedIn profile says she was director of coverage policy in the Office of Health Reform at HHS from April 2010 to December 2012 and then director of policy and regulation at CMS from December 2012 to May 2014. Politico describes her as having launched the ACA.
Her LinkedIn profile says she has a master of public policy degree from Georgetown and a bachelor's degree from Princeton.
If Biden nominates Brooks-LaSure as his CMS administrator, that would leave the FDA commissioner as the most prominent health position for which Biden hasn’t made a selection.
CMS administrators need to be confirmed by the Senate, so Biden can nominate someone but can‘t name to the person to the position outright.
Biden’s other picks for top health positions include Xavier Becerra, the California attorney general, for HHS secretary; Vivek Murthy, a surgeon general during the Obama administration for a return to that position; and Rochelle Walensky, for director of the CDC. The Senate doesn’t confirm CDC directors so Walensky has officially taken that position.
If Brooks-LaSure is confirmed, she would succeed Seema Verma as CMS administrator.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More